CBL Deletion in Stage II Melanoma: Why Statistics Matter Before Calling It a Prognostic Biomarker
A new correspondence in the British Journal of Cancer cautions that unadjusted statistical significance and sub-stage confounding must be resolved ...
A new correspondence in the British Journal of Cancer cautions that unadjusted statistical significance and sub-stage confounding must be resolved ...
A new commentary argues that exceptional long-term responses to melflufen-dexamethasone in myeloma case reports should not override subgroup trial evidence ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine